• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Novo has Takeda's diabetes trade secrets now that CH is there

anonymous

Guest
Bad enough the best Takeda legacy reps went to Novo, they are now getting people at the top level. This will be the end of the Takeda diabetes franchise as we know it.
 

<